Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanism and Response of Thymoglobulin in Patients With Myelodysplastic Syndrome (MDS)

NCT00466843 is registered in ClinicalTrials.gov with Office of Rare Diseases (ORD) as lead sponsor.

NCT NCT00466843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00466843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanism and Response of Thymoglobulin in Patients With Myelodysplastic Syndrome (MDS)
Lead sponsor
Office of Rare Diseases (ORD)
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2007
Completion date
February 28, 2010
Enrollment
54 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome